| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $127.7M | -19.3% |
| Cost of Revenue | $99.2M | -12.2% |
| Gross Profit | $28.5M | -37.0% |
| R&D Expense | $16.8M | +54.2% |
| SG&A Expense | $95.1M | +18.9% |
| Operating Income | -$213.9M | -60.3% |
| Interest Expense | $18.1M | -29.4% |
| Pre-tax Income | -$315.6M | -6.7% |
| Income Tax | -$21.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $87.1M | +73.8% |
| Accounts Receivable | $22.7M | -41.7% |
| Current Assets | $330.5M | +252.6% |
| Total Assets | $894.5M | +160.2% |
| Current Liabilities | $185.5M | -8.6% |
| Long-term Debt | $107.0M | -21.4% |
| Total Liabilities | $282.7M | -18.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.0M | -10.1% |
| Capital Expenditures | $525K | +8.5% |
| Investing Cash Flow | -$606.7M | — |
| Financing Cash Flow | $691.3M | +1217.8% |
| Free Cash Flow | -$42.5M | -10.0% |
| -8385.2% |
| Net Income | -$293.9M | +0.6% |
| EPS (Basic) | -$0.82 | +35.4% |
| EPS (Diluted) | -$0.82 | +35.4% |
| Stockholders' Equity |
| $611.9M |
| — |